Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2017-000314-29Phase 4Active
Phase 4, randomised trial of PRGF-Endoret in stasis ulcer (2 arms), sponsored by Hospital Universitario La Paz. Primary endpoint: Ulcer area reduction. Started Mar 2017; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2017-000314-29.